KD Logo

Investing in FibroGen Inc (FGEN): What You Must Know

FibroGen Inc’s recent filing unveils that its CEO Wettig Thane acquired Company’s shares for reported $95470.0 on Mar 07 ’24. In the deal valued at $1.91 per share,50,000 shares were bought. As a result of this transaction, Wettig Thane now holds 470,178 shares worth roughly $0.53 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Then, Henderson Jeffrey William sold 2,000 shares, generating $2,060 in total proceeds. Upon selling the shares at $1.03, the Director now owns 28,866 shares.

Before that, Henderson Jeffrey William sold 2,000 shares. FibroGen Inc shares valued at $3,820 were divested by the Director at a price of $1.91 per share. As a result of the transaction, Henderson Jeffrey William now holds 30,866 shares, worth roughly $34878.579999999994.

BofA Securities downgraded its FibroGen Inc [FGEN] rating to an Underperform from a a Neutral in a research note published on August 08, 2023; the price target was decreased to $2 from $4. A number of analysts have revised their coverage, including William Blair’s analysts, who decreased its forecast for the stock in late June from “an Outperform” to “a Mkt perform”. Stifel also remained covering FGEN and has decreased its forecast on June 26, 2023 with a “Hold” recommendation from previously “Buy” rating. Raymond James revised its rating on June 26, 2023. It rated FGEN as “a Mkt perform” which previously was an “an Outperform”.

Price Performance Review of FGEN

On Monday, FibroGen Inc [NASDAQ:FGEN] saw its stock jump 2.73% to $1.13. Over the last five days, the stock has lost -8.13%. FibroGen Inc shares have risen nearly 27.50% since the year began. Nevertheless, the stocks have fallen -93.64% over the past one year. While a 52-week high of $18.21 was reached on 02/12/24, a 52-week low of $0.33 was recorded on 01/05/24. SMA at 50 days reached $1.2725, while 200 days put it at $1.1602. A total of 1.33 million shares were traded, compared to the trading of 1.94 million shares in the previous session.

Levels Of Support And Resistance For FGEN Stock

The 24-hour chart illustrates a support level at 1.0633, which if violated will result in even more drops to 0.9967. On the upside, there is a resistance level at 1.1833. A further resistance level may holdings at 1.2367. The Relative Strength Index (RSI) on the 14-day chart is 42.93, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0629, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.18%. Stochastics %K at 22.71% indicates the stock is a holding.

Most Popular